keyword
https://read.qxmd.com/read/38828727/calcineurin-inhibition-rescues-alloantigen-specific-central-memory-t-cell-subsets-that-promote-chronic-gvhd
#1
JOURNAL ARTICLE
Yewei Wang, Md Ashik Ullah, Olivia G Waltner, Shruti S Bhise, Kathleen S Ensbey, Christine R Schmidt, Samuel Rw Legg, Tomoko Sekiguchi, Ethan L Nelson, Rachel D Kuns, Nicole S Nemychenkov, Erden Atilla, Albert C Yeh, Shuichiro Takahashi, Julie R Boiko, Antiopi Varelias, Bruce R Blazar, Motoko Koyama, Simone A Minnie, Andrew D Clouston, Scott N Furlan, Ping Zhang, Geoffrey R Hill
Calcineurin inhibitors (CNIs) constitute the backbone of modern acute graft-versus-host disease (aGVHD) prophylaxis regimens but have limited efficacy in the prevention and treatment of chronic GVHD (cGVHD). We investigated the effect of CNIs on immune tolerance after stem cell transplantation with discovery-based single-cell gene expression and T cell receptor (TCR) assays of clonal immunity in tandem with traditional protein-based approaches and preclinical modeling. While cyclosporin and tacrolimus suppressed the clonal expansion of CD8+ T cells during GVHD, alloreactive CD4+ T cell clusters were preferentially expanded...
June 3, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38824202/mitochondrial-rna-modification-based-signature-to-predict-prognosis-of-lower-grade-glioma-a-multi-omics-exploration-and-verification-study
#2
JOURNAL ARTICLE
Xingwang Zhou, Yuanguo Ling, Junshuan Cui, Xiang Wang, Niya Long, Wei Teng, Jian Liu, Xin Xiang, Hua Yang, Liangzhao Chu
Mitochondrial RNA modification (MRM) plays a crucial role in regulating the expression of key mitochondrial genes and promoting tumor metastasis. Despite its significance, comprehensive studies on MRM in lower grade gliomas (LGGs) remain unknown. Single-cell RNA-seq data (GSE89567) was used to evaluate the distribution functional status, and correlation of MRM-related genes in different cell types of LGG microenvironment. We developed an MRM scoring system by selecting potential MRM-related genes using LASSO regression analysis and the Random Survival Forest algorithm, based on multiple bulk RNA-seq datasets from TCGA, CGGA, GSE16011, and E-MTAB-3892...
June 1, 2024: Scientific Reports
https://read.qxmd.com/read/38818665/oclacitinib-therapy-in-two-cats-with-refractory-proliferative-and-necrotising-otitis-externa
#3
Tim Chan, Sandra Nogueira Koch, Samuel Devine, Ekaterina Mendoza-Kuznetsova
Feline proliferative and necrotising otitis externa (PNOE) is a rare immune-mediated condition, usually self-limiting or responsive to immunosuppressants such as topical tacrolimus. This case report describes two cats with refractory PNOE that responded successfully to oclacitinib. One cat also had middle ear involvement and the other cat had extra-auricular dermatitis.
May 31, 2024: Veterinary Dermatology
https://read.qxmd.com/read/38817698/sinus-bradycardia-as-a-rare-adverse-event-in-patients-receiving-cyclosporine-a-after-allogeneic-hematopoietic-stem-cell-transplantation
#4
JOURNAL ARTICLE
Magdalena Karasek, Maciej Majcherek, Bartłomiej Kuszczak, Agnieszka Szeremet, Olga Chyrko, Tomasz Wróbel, Anna Czyż
Cyclosporine A (CSA) is a commonly used immunosuppressive agent for the prophylaxis of graft-versus-host disease following allogeneic hematopoietic stem cell transplantation (alloHSCT). While tachycardia is a known adverse effect of CSA, bradycardia remains a phenomenon rarely described in the literature. We conducted a retrospective evaluation of the incidence of bradycardia in patients after alloHSCT treated with CSA between January 2020 and February 2023 at our center. Out of 206 patients, sinus bradycardia following the administration of CSA was observed in 6 (2...
2024: Clinical hematology international
https://read.qxmd.com/read/38817459/vitiligo-and-prostate-cancer-correlation
#5
Richard L Siwicki, Jeremy Shore, Robert A Norman
A 72-year-old male with a history of systemic hypertension, asthma, chronic obstructive pulmonary disease (COPD), and hyperlipidemia presents with diffuse patches of cutaneous depigmentation. A shave biopsy of different regions of depigmented skin indicated vitiligo. The patient was prescribed Opzelura (ruxolitinib) 1.5% topical cream as well as tacrolimus 0.1% topical ointment for vitiligo. He also had a history of prostate cancer. A prostate biopsy revealed three sites of prostatic adenocarcinoma with a Gleason score of 6 and a Prostate Imaging-Reporting and Data System (PI-RADS) score of 2...
April 2024: Curēus
https://read.qxmd.com/read/38815414/progressive-pulmonary-fibrosis-ppf-estimation-of-incidence-and-treatment-rates-in-japan-using-a-claims-database
#6
JOURNAL ARTICLE
Yasuhiro Kondoh, Tomohiro Ito, Kumiko Saito, Haikun Bao, Wataru Sakamoto
BACKGROUND: Interstitial lung diseases (ILDs) are a heterogeneous group of disorders, a subset of which develop progressive pulmonary fibrosis (PPF). There is little information on the epidemiology and treatment of PPFs in Japan. This retrospective cohort study estimated the incidence probability of progression to PPFs in patients with fibrosing ILDs other than idiopathic pulmonary fibrosis in a real-world Japanese setting. Management procedures and treatment patterns were also quantified...
May 29, 2024: Respiratory Investigation
https://read.qxmd.com/read/38814512/impact-of-intra-patient-variability-of-tacrolimus-on-allograft-function-and-cd4%C3%A2-%C3%A2-cd8%C3%A2-%C3%A2-ratio-in-kidney-transplant-recipients-a-retrospective-single-center-study
#7
JOURNAL ARTICLE
Xuebin Wang, Zhengyue Liu, Jingxia Chen, Yuhui Chai, Xueqing Shao, Wenmin Xie, Kaile Zheng, Jia You, Zhuo Wang, Meiqing Feng
BACKGROUND: Tacrolimus is a critical component of immunosuppressive therapy for kidney transplant recipients. Intra-patient variation (IPV) of tacrolimus levels affects the function of transplanted kidney. AIM: This study aimed to investigate the impact of tacrolimus IPV on kidney function, examine its association with post-transplant duration, and assess its effect on the immune status of transplant recipients. METHOD: This retrospective study was conducted from January 2016 to February 2022...
May 30, 2024: International Journal of Clinical Pharmacy
https://read.qxmd.com/read/38809924/deciphering-molecular-bridges-unveiling-the-interplay-between-metabolic-syndrome-and-alzheimer-s-disease-through-a-systems-biology-approach-and-drug-repurposing
#8
JOURNAL ARTICLE
Zahra Azizan, Hakimeh Zali, Seyed Amir Mirmotalebisohi, Maryam Bazrgar, Abolhassan Ahmadiani
The association between Alzheimer's disease and metabolic disorders as significant risk factors is widely acknowledged. However, the intricate molecular mechanism intertwining these conditions remains elusive. To address this knowledge gap, we conducted a thorough investigation using a bioinformatics method to illuminate the molecular connections and pathways that provide novel perspectives on these disorders' pathological and clinical features. Microarray datasets (GSE5281, GSE122063) from the Gene Expression Omnibus (GEO) database facilitated the way to identify genes with differential expression in Alzheimer's disease (141 genes)...
2024: PloS One
https://read.qxmd.com/read/38809527/chronic-pruritus-a-review
#9
JOURNAL ARTICLE
Daniel C Butler, Timothy Berger, Sarina Elmariah, Brian Kim, Sarah Chisolm, Shawn G Kwatra, Nicholas Mollanazar, Gil Yosipovitch
IMPORTANCE: Chronic pruritus, defined as itch experienced for 6 weeks or longer, affects approximately 22% of people in their lifetime. Approximately 1% of physician visits are for the chief concern of chronic pruritus. Chronic pruritus is associated with adverse outcomes, including impaired sleep and reduced quality of life. OBSERVATIONS: Chronic pruritus can be categorized by etiology into inflammatory, neuropathic, or a combination of inflammatory and neuropathic pruritus...
May 29, 2024: JAMA
https://read.qxmd.com/read/38808701/bk-polyomavirus-dnaemia-allograft-rejection-and-de-novo-donor-specific-antibodies-after-lowering-target-tacrolimus-levels-in-pediatric-kidney-transplant-recipients
#10
JOURNAL ARTICLE
Hou-Xuan Huang, Yijin Xiang, Roshan George, Pamela Winterberg, Anastacia Serluco, Rochelle Liverman, Inci Yildirim, Rouba Garro
BACKGROUND: BK polyomavirus (BKV) DNAemia is a challenging infectious complication after kidney transplant (KT). Reduction of immunosuppression is the mainstay of management, and tacrolimus is often the first immunosuppressive medication adjusted upon the diagnosis of BKV DNAemia. This study aimed to evaluate the impact of a new institutional protocol with lower target tacrolimus levels on BKV DNAemia, allograft rejection, and de novo donor-specific antibodies (dnDSA) among pediatric KT recipients...
August 2024: Pediatric Transplantation
https://read.qxmd.com/read/38807049/management-of-immunosuppression-in-lung-transplant-recipients-and-covid-19-outcomes-an-observational-retrospective-cohort-study
#11
JOURNAL ARTICLE
Hugo Bes-Berlandier, Benjamin Coiffard, Julien Bermudez, Nadine Demazes-Dufeu, Bérengère Coltey, Céline Boschi, Philippe Colson, Sami Hraiech, Martine Reynaud-Gaubert, Nadim Cassir
BACKGROUND: The aim of this study was to assess the impact of immunosuppression management on coronavirus disease 2019 (COVID-19) outcomes. METHODS: We performed a single-center retrospective study in a cohort of 358 lung transplant recipients (LTx) over the period from March 2020 to April 2022. All included symptomatic patients had at least one positive SARS-CoV-2 rt-PCR. We used a composite primary outcome for COVID-19 including increased need for oxygen since the hospital admission, ICU transfer, and in-hospital mortality...
May 28, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38806494/multi-omics-in-nasal-epithelium-reveals-three-axes-of-dysregulation-for-asthma-risk-in-the-african-diaspora-populations
#12
JOURNAL ARTICLE
Brooke Szczesny, Meher Preethi Boorgula, Sameer Chavan, Monica Campbell, Randi K Johnson, Kai Kammers, Emma E Thompson, Madison S Cox, Gautam Shankar, Corey Cox, Andréanne Morin, Wendy Lorizio, Michelle Daya, Samir N P Kelada, Terri H Beaty, Ayo P Doumatey, Alvaro A Cruz, Harold Watson, Edward T Naureckas, B Louise Giles, Ganiyu A Arinola, Olumide Sogaolu, Adegoke G Falade, Nadia N Hansel, Ivana V Yang, Christopher O Olopade, Charles N Rotimi, R Clive Landis, Camila A Figueiredo, Matthew C Altman, Eimear Kenny, Ingo Ruczinski, Andrew H Liu, Carole Ober, Margaret A Taub, Kathleen C Barnes, Rasika A Mathias
Asthma has striking disparities across ancestral groups, but the molecular underpinning of these differences is poorly understood and minimally studied. A goal of the Consortium on Asthma among African-ancestry Populations in the Americas (CAAPA) is to understand multi-omic signatures of asthma focusing on populations of African ancestry. RNASeq and DNA methylation data are generated from nasal epithelium including cases (current asthma, N = 253) and controls (never-asthma, N = 283) from 7 different geographic sites to identify differentially expressed genes (DEGs) and gene networks...
May 28, 2024: Nature Communications
https://read.qxmd.com/read/38804401/safety-and-efficacy-of-very-early-conversion-to-belatacept-in-pediatric-kidney-transplantation-with-transplant-associated-thrombotic-microangiopathy-case-study-and-review-of-literature
#13
Ratna Acharya, William Clapp, Kiran Upadhyay
The inhibition of co-stimulation during T-cell activation has been shown to provide effective immunosuppression in kidney transplantation (KT). Hence, the conversion from calcineurin inhibitor (CNI) to belatacept is emerging as a potential alternate maintenance immunosuppressive therapy in those with transplant-associated thrombotic microangiopathy (TA-TMA) or in the prevention of TA-TMA. We present a 17-year-old male who presented with biopsy-proven CNI-associated TA-TMA immediately post-KT. The administration of eculizumab led to the reversal of TMA...
May 16, 2024: Clinics and Practice
https://read.qxmd.com/read/38803221/nfat-activation-by-fkbp52-promotes-cancer-cell-proliferation-by-suppressing-p53
#14
JOURNAL ARTICLE
Shunsuke Hanaki, Makoto Habara, Haruki Tomiyasu, Yuki Sato, Yosei Miki, Takahiro Masaki, Shusaku Shibutani, Midori Shimada
FK506-binding protein 52 (FKBP52) is a member of the FKBP family of proline isomerases. FKBP52 is up-regulated in various cancers and functions as a positive regulator of steroid hormone receptors. Depletion of FKBP52 is known to inhibit cell proliferation; however, the detailed mechanism remains poorly understood. In this study, we found that FKBP52 depletion decreased MDM2 transcription, leading to stabilization of p53, and suppressed cell proliferation. We identified NFATc1 and NFATc3 as transcription factors that regulate MDM2 We also found that FKBP52 associated with NFATc3 and facilitated its nuclear translocation...
August 2024: Life Science Alliance
https://read.qxmd.com/read/38801991/invasive-aspergillosis-in-liver-transplant-recipients-in-the-current-era
#15
JOURNAL ARTICLE
Muneyoshi Kimura, Matteo Rinaldi, Sagar Kothari, Maddalena Giannella, Shweta Anjan, Yoichiro Natori, Pakpoom Phoompoung, Emily Gault, Jonathan Hand, Matilde D'Asaro, Dionysios Neofytos, Nicolas J Mueller, Andreas E Kremer, Tereza Rojko, Marija Ribnikar, Fernanda P Silveira, Joshua Kohl, Angela Cano, Julian Torre-Cisneros, Rafael San-Juan, Jose Maria Aguado, Armaghan-E-Rehman Mansoor, Ige Abraham George, Alessandra Mularoni, Giovanna Russelli, Me-Linh Luong, Yamama A AlJishi, Maram N AlJishi, Bassem Hamandi, Nazia Selzner, Shahid Husain
Invasive aspergillosis (IA) is a rare but fatal disease among liver transplant recipients (LiTRs). We performed a multi-center 1:2 case-control study comparing LiTRs diagnosed with proven/probable IA and controls with no invasive fungal infection. We included 62 IA cases and 124 matched controls. Disseminated infection occurred only in eight cases (13%). 12-week all-cause mortality of IA was 37%. In multivariate analyses, systemic antibiotics usage (adjusted odds ratio [aOR], 4.74; p=0.03) and history of pneumonia (aOR, 48...
May 25, 2024: American Journal of Transplantation
https://read.qxmd.com/read/38801378/audiological-follow-up-in-transplant-patients-treated-with-calcineurin-immunosuppressants-calcineurin-inhibitors-and-ototoxicity
#16
JOURNAL ARTICLE
Claudia Heider, Sofia Waissbluth, Javier Oyarzún, Gabriela Calderara, Jai-Sen Leung, Ivún Novoa
BACKGROUND: Ototoxicity is a side effect of drugs and medications that usually leads to bilateral and symmetric sensorineural hearing loss that commonly affects the high-frequency range initially, with or preceded by tinnitus. Possible ototoxic side effects of calcineurin inhibitor immunosuppressants have been suggested, but this remains unclear. Therefore, this study aims to evaluate audiological changes in patients undergoing transplantation receiving immunosuppressive treatment with calcineurin inhibitors...
June 2023: Revista Médica de Chile
https://read.qxmd.com/read/38799982/hemophagocytic-lymphohistiocytosis-in-a-remote-kidney-transplant-recipient-triggered-by-hsv-infection-with-complete-recovery-an-educational-case-report
#17
Anjana Gopal, S Joseph Kim
RATIONALE: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease characterized by excessive immune activation. It is more commonly seen in children but increasingly recognized in adults. Primary HLH relies on a genetic predisposition, whereas secondary HLH develops in the context of infections, malignancies, or autoimmune diseases. Hemophagocytic lymphohistiocytosis has been rarely described in patients on immunosuppressive therapy after kidney transplant. Here, we describe a case of HLH in a patient with a remote history of kidney transplant, triggered by a viral infection...
2024: Canadian Journal of Kidney Health and Disease
https://read.qxmd.com/read/38799658/nonperturbative-fluorogenic-labeling-of-immunophilins-enables-the-wash-free-detection-of-immunosuppressants
#18
JOURNAL ARTICLE
Marco Bertolini, Lorena Mendive-Tapia, Ouldouz Ghashghaei, Abigail Reese, Charles Lochenie, Anna M Schoepf, Miquel Sintes, Karolina Tokarczyk, Zandile Nare, Andrew D Scott, Stephen R Knight, Advait R Aithal, Amit Sachdeva, Rodolfo Lavilla, Marc Vendrell
Immunosuppressants are clinically approved drugs to treat the potential rejection of transplanted organs and require frequent monitoring due to their narrow therapeutic window. Immunophilins are small proteins that bind immunosuppressants with high affinity, yet there are no examples of fluorogenic immunophilins and their potential application as optical biosensors for immunosuppressive drugs in clinical biosamples. In the present work, we designed novel diazonium BODIPY salts for the site-specific labeling of tyrosine residues in peptides via solid-phase synthesis as well as for late-stage functionalization of whole recombinant proteins...
May 22, 2024: ACS Central Science
https://read.qxmd.com/read/38799459/pharmacodynamic-monitoring-by-residual-gene-expression-of-the-nuclear-factor-of-activated-t-cell-regulated-genes-in-lung-transplant-recipients-and-its-correlation-with-tacrolimus-blood-levels
#19
JOURNAL ARTICLE
Meritxell Boada-Pérez, Victoria Ruiz de Miguel, Marta Erro, Piedad Ussetti, Myriam Aguilar, Raquel Castejón, Silvia Rosado, Roser Escobar-Fornieles, Eva Revilla-López, Carlos Bravo, Berta Sáez-Giménez, Marta Zapata-Ortega, Yolanda Villena-Ortiz, Jaume Vima-Bofarull, Víctor Monforte, Susana Gómez-Ollés
INTRODUCTION: Trough blood levels (C0 ) of tacrolimus are used to adjust drug dosage, but they do not consistently correlate with clinical outcomes. Measurement of residual gene expression of nuclear factor of activated T cell (NFAT)-regulated genes (NFAT-RGE) has been proposed as a pharmacodynamic biomarker to assess the degree of immunosuppression in certain solid organ transplantations, but little is known regarding lung transplant recipients (LTR). Our primary objective is to correlate tacrolimus blood levels with NFAT-RGE...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38798824/akap5-links-synaptic-dysfunction-to-neuroinflammatory-signaling-in-a-mouse-model-of-infantile-neuronal-ceroid-lipofuscinosis
#20
JOURNAL ARTICLE
Kevin P Koster, Zach Fyke, Thu T A Nguyen, Amanda Niqula, Lorena Y Noriega-González, Kevin M Woolfrey, Mark L Dell'Acqua, Stephanie M Cologna, Akira Yoshii
Palmitoylation and depalmitoylation represent dichotomic processes by which a labile posttranslational lipid modification regulates protein trafficking and degradation. The depalmitoylating enzyme, palmitoyl-protein thioesterase 1 (PPT1), is associated with the devastating pediatric neurodegenerative condition, infantile neuronal ceroid lipofuscinosis (CLN1). CLN1 is characterized by the accumulation of autofluorescent lysosomal storage material (AFSM) in neurons and robust neuroinflammation. Converging lines of evidence suggest that in addition to cellular waste accumulation, the symptomology of CLN1 corresponds with disruption of synaptic processes...
2024: Frontiers in Synaptic Neuroscience
keyword
keyword
4703
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.